July 19, 2016
Bayer Yakuhin has entered into a licensing and commercialization agreement with Taisho Pharmaceutical, granting the Japanese company the rights to market a switch OTC version of the allergy drug Claritin (loratadine) in Japan. Bayer Yakuhin is already seeking regulators’ greenlight...read more